logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 13
  • 1
    O'rourke, Michael Joseph
    Born in March 1959
    Individual (1 offspring)
    Officer
    2017-05-13 ~ now
    OF - Director → CIF 0
  • 2
    Wilson, Henry Richard Ernest
    Venture Capitalist born in October 1966
    Individual (37 offsprings)
    Officer
    2017-11-24 ~ 2020-05-29
    OF - Director → CIF 0
  • 3
    Hamontree, Garrett
    Born in July 1989
    Individual (1 offspring)
    Officer
    2020-05-29 ~ now
    OF - Director → CIF 0
  • 4
    Avery, Robert Logan, Dr
    Born in May 1960
    Individual (1 offspring)
    Officer
    2022-11-28 ~ now
    OF - Director → CIF 0
  • 5
    Thakur, Raghu Raj Singh, Dr
    Lecturer In Pharmaceutics born in September 1979
    Individual (3 offsprings)
    Officer
    2016-07-29 ~ 2022-11-28
    OF - Director → CIF 0
    Dr. Raghu Raj Singh Thakur
    Born in September 1979
    Individual (3 offsprings)
    Person with significant control
    2016-05-16 ~ 2017-12-13
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 6
    Grundy, Robert Ian
    Company Director born in January 1975
    Individual (6 offsprings)
    Officer
    2016-05-16 ~ 2017-05-15
    OF - Director → CIF 0
  • 7
    Jones, David Simon, Dr
    Born in May 1963
    Individual (3 offsprings)
    Officer
    2016-05-16 ~ 2017-12-07
    OF - Director → CIF 0
  • 8
    Sharkey, James Anthony
    Medical Practitioner born in December 1961
    Individual (7 offsprings)
    Officer
    2017-11-24 ~ 2021-11-17
    OF - Director → CIF 0
  • 9
    Rooney, Kieran Francis, Dr
    Director born in September 1960
    Individual (2 offsprings)
    Officer
    2017-09-29 ~ 2022-11-28
    OF - Director → CIF 0
  • 10
    Sumeray, Anna
    Born in July 1965
    Individual (1 offspring)
    Officer
    2021-11-17 ~ now
    OF - Director → CIF 0
  • 11
    Murray, James
    Born in April 1981
    Individual (7 offsprings)
    Officer
    2020-03-20 ~ now
    OF - Director → CIF 0
  • 12
    Mccaul, Brian Aidan
    Director Of Innovation born in October 1966
    Individual (30 offsprings)
    Officer
    2016-05-09 ~ 2022-11-28
    OF - Director → CIF 0
  • 13
    QUBIS LIMITED
    NI017859
    63, University Road, Belfast, Northern Ireland
    Active Corporate (57 parents, 23 offsprings)
    Person with significant control
    2016-05-16 ~ 2017-12-13
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

RE-VANA THERAPEUTICS LTD

Period: 2016-05-17 ~ now
Company number: NI638333
Registered names
RE-VANA THERAPEUTICS LTD - now
REVANA OCULAR LTD - 2016-05-17
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
72024-06-01 ~ 2025-05-31
32023-06-01 ~ 2024-05-31
Property, Plant & Equipment
223,930 GBP2025-05-31
233,766 GBP2024-05-31
Debtors
Current
284,937 GBP2025-05-31
216,839 GBP2024-05-31
Cash at bank and in hand
2,950,688 GBP2025-05-31
5,533,346 GBP2024-05-31
Current Assets
3,235,625 GBP2025-05-31
5,750,185 GBP2024-05-31
Creditors
Current, Amounts falling due within one year
-214,199 GBP2024-05-31
Net Current Assets/Liabilities
3,045,586 GBP2025-05-31
5,587,880 GBP2024-05-31
Total Assets Less Current Liabilities
3,269,516 GBP2025-05-31
5,821,646 GBP2024-05-31
Net Assets/Liabilities
3,088,809 GBP2025-05-31
5,820,296 GBP2024-05-31
Property, Plant & Equipment - Gross Cost
Tools/Equipment for furniture and fittings
23,733 GBP2025-05-31
17,093 GBP2024-05-31
Other
365,231 GBP2025-05-31
302,042 GBP2024-05-31
Property, Plant & Equipment - Gross Cost
388,964 GBP2025-05-31
319,135 GBP2024-05-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Tools/Equipment for furniture and fittings
14,388 GBP2025-05-31
7,769 GBP2024-05-31
Other
150,646 GBP2025-05-31
77,600 GBP2024-05-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
165,034 GBP2025-05-31
85,369 GBP2024-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Tools/Equipment for furniture and fittings
6,619 GBP2024-06-01 ~ 2025-05-31
Other
73,046 GBP2024-06-01 ~ 2025-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
79,665 GBP2024-06-01 ~ 2025-05-31
Property, Plant & Equipment
Tools/Equipment for furniture and fittings
9,345 GBP2025-05-31
9,324 GBP2024-05-31
Other
214,585 GBP2025-05-31
224,442 GBP2024-05-31
Par Value of Share
Class 1 ordinary share
0.002024-06-01 ~ 2025-05-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
582,508 shares2025-05-31
582,508 shares2024-05-31
Number of Shares Issued (Fully Paid)
2,096,941 shares2025-05-31
2,096,941 shares2024-05-31
Nominal value of allotted share capital
210 GBP2024-06-01 ~ 2025-05-31
210 GBP2023-06-01 ~ 2024-05-31
Director Remuneration
213,596 GBP2024-06-01 ~ 2025-05-31
329,087 GBP2023-06-01 ~ 2024-05-31

  • RE-VANA THERAPEUTICS LTD
    Info
    REVANA OCULAR LTD - 2016-05-17
    Registered number NI638333
    Catalyst - Concourse 3, 15 Queens Road, Belfast BT3 9DT
    PRIVATE LIMITED COMPANY incorporated on 2016-05-09 (9 years 11 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-03-14
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.